Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT April 24, 2024
A Jewish American and a Palestinian American are tackling science’s toughest challenges February 23, 2024
Weeks after $213M launch, Tome acquires a Berkeley gene editing startup for DNA ligase technology January 2, 2024
